Search Results 501-510 of 66611 for Cancer
Breast Cancer. Polygenic risk. People with high polygenic risk scores are 1.6 to 2.5 times more likely to get breast cancer than are people who aren't in ...
Cellular therapy for hematological cancers. Our lab has extensive experience conducting leading-edge research and clinical trials in cellular therapy. Our goal ...
Breast cancer screening, limited by its broad primarily age-based approach, is evolving. Integrating polygenic risk scores with traditional assessment ...
Blood in the urine (hematuria) sometimes is a sign of bladder cancer. Learn about other bladder cancer signs and symptoms and explore treatment options.
... cancer signal origin(s) to determine if they have cancer. The number and types of diagnostic procedures required to achieve diagnostic resolution will be ...
The field of endometrial cancer is evolving rapidly, moving toward molecular risk stratification and targeted therapy using a team science approach.
About this study. This is an international phase III trial, with a Bayesian design, incorporating two sequential randomisations. It efficiently examines a ...
Learn about symptoms, risk factors, diagnosis and treatment, including transplant, for this rare cancer that affects the bile ducts of older adults.
Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no clinical evidence of ...
Some grow slowly and aren't considered to be cancers. Others are considered cancerous. Another word for cancerous is malignant. Malignant gliomas grow quickly ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Benefactor support fuels Mayo Clinic’s groundbreaking research. Make a gift today to help us save lives.